Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism.

Saved in:
Bibliographic Details
Title: Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism.
Authors: Shi J; Department of Clinical Pharmacy, University of Michigan, Ann Arbor, Michigan, USA., Xiao J; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA., Wang X; Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, USA., Jung SM; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA., Bleske BE; Department of Pharmacy Practice and Administrative Sciences, The University of New Mexico, Albuquerque, New Mexico, USA., Markowitz JS; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida, USA., Patrick KS; Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA., Zhu HJ; Department of Clinical Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Apr; Vol. 111 (4), pp. 878-885. Date of Electronic Publication: 2021 Nov 30.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1532-6535
DOI:10.1002/cpt.2486